Press release
Anti‐Obesity Drugs Market to Reach USD 77.2 B by 2030 at ~42% CAGR
Anti-Obesity Prescription Drugs Market
According to Grand View Research, the global anti‐obesity medication market generated approximately USD 6,615 million in 2023 and is projected to reach USD 77,240 million by 2030, expanding at a robust CAGR of 42.1% from 2024 to 2030
Parallel estimates from ResearchAndMarkets suggest growth from USD 3.2 B in 2023 to USD 11.3 B by 2028 (CAGR ~28.9%)
Download your sample copy of this report today! https://www.maximizemarketresearch.com/request-sample/36441/
◉ Market Overview & Growth Drivers
Rising global obesity prevalence, increasing health awareness, and escalating R&D investments are fueling market expansion
Prescription drugs dominate, commanding over 80% share globally, while injectable GLP‐1 and dual/triple agonists like semaglutide, tirzepatide, and emerging combinations are key growth drivers
Emerging oral GLP‐1 agonists are expected to expand rapidly (projected ~36.6% CAGR) due to greater convenience and patient adherence
Secure your sample copy of this report immediately!https://www.maximizemarketresearch.com/request-sample/36441/
◉ Competitive Landscape
Market leaders include Novo Nordisk (semaglutide, Wegovy/Ozempic), Eli Lilly (tirzepatide, Zepbound), Pfizer (developing oral danuglipron), along with other companies like Roche, GlaxoSmithKline, Novartis, and Rhythm Pharmaceuticals
Recent major moves:
Roche acquired Carmot Therapeutics (CT‐388 obesity candidate) for USD 2.7B
Eli Lilly obtained FDA approval in Nov 2023 for Zepbound, a dual GIP/GLP‐1 agonist, and is investing USD 2.5B in German production capacity
◉ Regional Demand & Higher Growth Region
North America led with ~37-46% revenue share in 2023-24; the U.S. is projected to reach ~USD 23.3 B by 2030
Asia‐Pacific is the fastest-growing region (CAGR ~30-33%), driven by rising obesity rates across China, India, and Southeast Asia
Europe displays steady expansion with regulatory support for obesity treatments and WHO‐level health awareness supporting drug uptake
◉ COUNTRY‐SPECIFIC INSIGHTS
Vietnam Opportunity Growth
Vietnam's obesity rates and urban middle-class health consciousness are increasing demand for GLP‐1 therapies-especially with expanding healthcare access and disease awareness.
Thailand Trends Growth
Thailand's growing healthcare spending and medical tourism sector are accelerating uptake of injectable and forthcoming oral anti‐obesity prescriptions.
Japan Consolidation Growth
Japanese healthcare providers are partnering with Novo Nordisk and Eli Lilly to integrate GLP‐1 therapies and combination agents into obesity management protocols.
South Korea Updation Innovation
South Korea is pursuing advanced therapies like CagriSema (cagrilintide + semaglutide), while preparing for oral candidates such as Pfizer's danuglipron and Eli Lilly's retatrutide
Singapore Benchmarking Opportunity
Singapore leads regional uptake of novel obesity drugs and clinical trials, offering early access to combination therapies and advanced injection regimens.
Consolidation Trends in the United States
The U.S., home base for Eli Lilly, Novo Nordisk, and others, continues dominating the pipeline, regulatory approvals (e.g. Zepbound), and capacity expansions (e.g. Lilly's Germany plant)
Growth in China Trends
China has the world's largest overweight population and is preparing for generics entry (post-2026) by local firms such as Huadong Medicine and Hangzhou Jiuyuan, spurred by Novo Nordisk and Lilly patent expirations
Opportunity & Compliance in Europe
Europe is strengthening integration of anti‐obesity medicines into public reimbursement frameworks and expanding access under EMA guidance; early access programs support combinations like CagriSema and oral GLP‐1 developments
To learn more about the findings of this research, please check:https://www.maximizemarketresearch.com/market-report/global-anti-obesity-prescription-drugs-market/36441/
◉ Anti-Obesity Prescription Drugs Market Segment Analysis
by Drug Type
Contrave
Belviq
Xenical
Saxenda
Qsymia
by Type
Prescription Drugs
OTC Drugs
by Drug class
Peripherally Acting Anti-obesity Drugs
Centrally Acting Anti-obesity Drugs
by Sales channel
Direct Channel
Distribution Channel
by Application
Hospitals Pharmacies
Retail Pharmacies
E-commerce
◉ Mergers, Pipeline & Regulatory Highlights
Roche's acquisition of Carmot Therapeutics (CT‐388) for USD 2.7B aims to broaden pipeline beyond GLP‐1 treatments
Eli Lilly secured FDA approval for Zepbound and expanded production capacity in Germany to meet demand surge
Pfizer's oral GLP‐1 agent danuglipron entered dose optimization studies in 2024, aiming for registration trials
Novo Nordisk's CagriSema combination demonstrated ~20.4% weight loss at 68 weeks in Phase III REDEFINE 1 trial
Eli Lilly's retatrutide triple‐agonist is expected to share results by end‐2025, potentially eclipsing existing therapies
◉ Key Recent Developments
In India, introduction of Wegovy and Mounjaro in 2025 has sparked a generics race involving Sun Pharma, Cipla, Dr. Reddy's, and Biocon, with generics expected as early as 2027
In China, over 15 domestic drugmakers (e.g., Hengrui Pharma) are developing alternatives to semaglutide, positioning the country for post‐patent competition by mid‐2026
Novo Nordisk and Eli Lilly continue to dominate global share-analyst forecasts estimate a combined share of ~80-82% through the late 2020s; UBS projects the obesity market could hit USD 150 B by 2029
◉ Get Market Research Latest Trends
Global Virus Filtration Market North America https://www.maximizemarketresearch.com/market-report/global-virus-filtration-market/10964/
Global Dental Adhesives & Sealants Market https://www.maximizemarketresearch.com/market-report/global-dental-adhesives-sealants-market/103325/
Global Patient Warming Systems Market https://www.maximizemarketresearch.com/market-report/global-patient-warming-systems-market/31514/
Global Antimicrobial Ingredients Market https://www.maximizemarketresearch.com/market-report/global-antimicrobial-ingredients-market/85303/
Therapeutic Respiratory Devices Market https://www.maximizemarketresearch.com/market-report/global-therapeutic-respiratory-devices-market/10111/
Electrophysiology Market https://www.maximizemarketresearch.com/market-report/global-electrophysiology-market/21498/
Follicular Lymphoma Treatment Market https://www.maximizemarketresearch.com/market-report/follicular-lymphoma-treatment-market/12594/
Global Capillary Electrophoresis Market https://www.maximizemarketresearch.com/market-report/global-capillary-electrophoresis-market/95834/
Global Protein Extracts from Single Cell Protein Sources Market https://www.maximizemarketresearch.com/market-report/global-protein-extracts-from-single-cell-protein-sources-market/87650/
Global Gastrointestinal Diseases Market https://www.maximizemarketresearch.com/market-report/gastrointestinal-diseases-market/304/
Global Kidney Stone Management Devices Market https://www.maximizemarketresearch.com/market-report/global-kidney-stone-management-devices-market/34959/
Global Orthopedic Surgical Power Tools Market https://www.maximizemarketresearch.com/market-report/global-orthopedic-surgical-power-tools-market/96822/
Global Clinical Trial Imaging Market https://www.maximizemarketresearch.com/market-report/global-clinical-trial-imaging-market/6603/
Diabetes Pen market https://www.maximizemarketresearch.com/market-report/global-diabetes-pen-market/53840/
◉Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656
◉About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anti‐Obesity Drugs Market to Reach USD 77.2 B by 2030 at ~42% CAGR here
News-ID: 4113797 • Views: …
More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.
Pyrolysis Oil Market: A Look at the Industry's Current and Future State
Pyrolysis Oil Market size was valued at USD 360.35 Million in 2024 and the market revenue is expected to grow at a CAGR of 4.2% from 2024 to 2032, reaching nearly USD 500.8 Million.
The Pyrolysis Oil Market is witnessing a significant transformation as industries seek sustainable and renewable alternatives to conventional fossil fuels. Pyrolysis oil, derived from the thermal decomposition of biomass or waste materials, is gaining traction for its…
India Metal Fabrication Equipment Market : A Breakdown of the Industry by Techno …
India Metal Fabrication Equipment Market has been estimated at US$ 92.13 Bn in 2023 and is projected to reach US$ 130.50 BN by 2030, at a CAGR of 5.1% during the forecast period.
The India Metal Fabrication Equipment market is undergoing significant transformation as digital technologies, data analytics, and AI-driven platforms reshape how policies are distributed and customized for clients. Brokers are moving beyond traditional policy placement to offer risk advisory…
Automatic Lubrication System Market: An In-Depth Look at the Current State and F …
The Automatic Lubrication System Market size was valued at USD 886.79 Billion in 2024 and the total Automatic Lubrication System revenue is expected to grow at a CAGR of 4.7% from 2025 to 2032, reaching nearly USD 1340.73 Billion.
The Automatic Lubrication System (ALS) market is witnessing a significant transformation as industries increasingly prioritize efficiency, equipment longevity, and safety. These systems provide precise and consistent lubrication to machinery, reducing wear and…
Kitchenware Market : A Look at the Industry's Advancements and Opportunities
The Kitchenware Market size was valued at USD 74.04 Billion in 2024 and the total Kitchenware revenue is expected to grow at a CAGR of 4.5% from 2025 to 2032, reaching nearly USD 105.30 Billion.
The Kitchenware Market has been experiencing a dynamic transformation as consumers increasingly prioritize convenience, efficiency, and aesthetics in their cooking environments. Modern kitchens are no longer just functional spaces-they are extensions of lifestyle, driving demand for…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
